Publication | Closed Access

Doxorubicin delivered by redox-responsive Hyaluronic Acid–Ibuprofen prodrug micelles for treatment of metastatic breast cancer

NanomedicineMetastatic Breast CancerEngineeringDrug TargetingPolymer-drug ConjugateMedicineDrug Delivery SystemsBreast CancerTumor TargetingNano-drug DeliveryBiomedical EngineeringMatrix BiologyDrug Delivery SystemPharmacology